161 related articles for article (PubMed ID: 35971851)
1. Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.
Scolari FL; Brahmbhatt DH; Abelson S; Medeiros JJF; Anker MS; Fung NL; Otsuki M; Calvillo-Argüelles O; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
Am J Transplant; 2022 Dec; 22(12):3078-3086. PubMed ID: 35971851
[TBL] [Abstract][Full Text] [Related]
2. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
[TBL] [Abstract][Full Text] [Related]
3. Clonal hematopoiesis of indeterminate potential and outcomes after heart transplantation: A multicenter study.
Amancherla K; Schlendorf KH; Vlasschaert C; Lowery BD; Wells QS; See SB; Zorn E; Colombo PC; Reilly MP; Lindenfeld J; Uriel N; Freedman JE; Shah RV; Moslehi J; Bick AG; Clerkin K
Am J Transplant; 2023 Aug; 23(8):1256-1263. PubMed ID: 37156299
[TBL] [Abstract][Full Text] [Related]
4. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract][Full Text] [Related]
5. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
Oran B; Champlin RE; Wang F; Tanaka T; Saliba RM; Al-Atrash G; Garcia-Manero G; Kantarjian H; Cao K; Shpall EJ; Alousi AM; Mehta RS; Popat U; Futreal A; Takahashi K
Leukemia; 2022 Jan; 36(1):257-262. PubMed ID: 34135465
[TBL] [Abstract][Full Text] [Related]
6. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.
Delgado JF; Reyne AG; de Dios S; López-Medrano F; Jurado A; Juan RS; Ruiz-Cano MJ; Dolores Folgueira M; Gómez-Sánchez MÁ; Aguado JM; Lumbreras C
J Heart Lung Transplant; 2015 Aug; 34(8):1112-9. PubMed ID: 25940077
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
[TBL] [Abstract][Full Text] [Related]
8. Impact of induction therapy on cytomegalovirus infection and post-transplant outcomes in pediatric heart transplant recipients receiving routine antiviral prophylaxis.
Zang S; Zhang X; Niu J; Das BB
Clin Transplant; 2023 Jan; 37(1):e14836. PubMed ID: 36259556
[TBL] [Abstract][Full Text] [Related]
9. The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection.
Clerkin KJ; Restaino SW; Zorn E; Vasilescu ER; Marboe CC; Mancini DM
J Heart Lung Transplant; 2016 Sep; 35(9):1059-66. PubMed ID: 27423693
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
[TBL] [Abstract][Full Text] [Related]
11. Clonal Hematopoiesis and the Heart: a Toxic Relationship.
Jensen JL; Easaw S; Anderson T; Varma Y; Zhang J; Jensen BC; Coombs CC
Curr Oncol Rep; 2023 May; 25(5):455-463. PubMed ID: 36920637
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipients.
Swaminathan AC; Barfield R; Zhang M; Povysil G; Chen C; Frankel C; Kelly F; McKinney M; Todd JL; Allen A; Palmer SM
BMC Pulm Med; 2023 Oct; 23(1):414. PubMed ID: 37904125
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection and allograft rejection among pediatric heart transplant recipients in the era of valganciclovir prophylaxis.
Das BB; Prusty BK; Niu J; Sue PK
Pediatr Transplant; 2020 Dec; 24(8):e13750. PubMed ID: 32573886
[TBL] [Abstract][Full Text] [Related]
14. Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation.
Tague LK; Oetjen KA; Mahadev A; Walter MJ; Anthony H; Kreisel D; Link DC; Gelman AE
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 36853803
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.
Johansson I; Andersson R; Friman V; Selimovic N; Hanzen L; Nasic S; Nyström U; Sigurdardottir V
BMC Infect Dis; 2015 Dec; 15():582. PubMed ID: 26703239
[TBL] [Abstract][Full Text] [Related]
16. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
[TBL] [Abstract][Full Text] [Related]
17. Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: Diagnostic accuracy and predictors of outcomes.
Chirakarnjanakorn S; Starling RC; Popović ZB; Griffin BP; Desai MY
J Heart Lung Transplant; 2015 May; 34(5):710-7. PubMed ID: 25682552
[TBL] [Abstract][Full Text] [Related]
18. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
20. Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock.
Scolari FL; Abelson S; Brahmbhatt DH; Medeiros JJF; Fan CS; Fung NL; Mihajlovic V; Anker MS; Otsuki M; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
Eur J Heart Fail; 2022 Sep; 24(9):1573-1582. PubMed ID: 35729851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
